Sagility Q2 FY27 Revenue Up 22.5% YoY to ₹2,032 Cr; Declares Interim Dividend
Sagility Limited reported Q2 FY27 revenue of ₹2,032 crore, up 22.5% YoY. Adjusted EBITDA grew 23.0% to ₹535 crore, and Adjusted PAT increased 8.1% to ₹325 crore. For H1 FY27, revenue rose 25.0% to ₹3,996 crore. The company declared an interim dividend of ₹0.15 per share. It also acquired Chirok Health LLC.
The announcement includes significant financial performance metrics showing substantial growth, a dividend declaration, and a strategic acquisition, all of which are material events for investors and stakeholders.
The company reported strong year-on-year growth in revenue, adjusted EBITDA, and adjusted PAT for both the quarter and half-year. The declaration of an interim dividend and strategic acquisitions further indicate positive performance and future outlook.
Sagility Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported strong performance with consolidated revenue for Q2 FY27 at ₹20,321 million (US$212.6 million), representing a Year-on-Year (YoY) growth of 22.5% (12.2% in constant currency). Organic YoY growth stood at 22.2% (11.9% in constant currency).
Adjusted EBITDA for the quarter was ₹5,353 million (US$56.0 million), a 23.0% YoY growth and stood at 26.3% of revenue. Adjusted Profit After Tax (PAT) was ₹3,254 million (US$34.0 million), up 8.1% YoY, representing 16.0% of revenue. Basic Earnings Per Share (EPS) was ₹0.61, with Adjusted Basic EPS at ₹0.70.
For the half-year ended September 30, 2026, revenue was ₹39,956 million (US$420.4 million), a 25.0% YoY growth (13.7% in constant currency). Adjusted EBITDA grew by 25.2% YoY to ₹10,069 million (US$105.9 million) at 25.2% of revenue. Adjusted PAT increased by 18.9% YoY to ₹5,951 million (US$62.6 million) at 14.9% of revenue. Basic EPS for the half-year was ₹1.07, and Adjusted Basic EPS was ₹1.27.
Business highlights include securing $40.2 million of Annual Contract Value (ACV) from existing clients and one new logo. The company added 28 client groups in H1 FY27, bringing the total active client group base to 105. Sagility also acquired Chirok Health LLC to enhance its Provider segment growth and CDI/coding capabilities.
The Board has declared an interim dividend of ₹0.15 per share. Ramesh Gopalan, Managing Director and Group CEO, commented on the broad-based momentum, healthy pipeline, and growing traction of AI solutions. Srinivas Mattapalli, Group Chief Financial Officer, highlighted the strong Q2 performance, robust cash generation, and the highest adjusted EBITDA margin in six quarters.
What to do with a filing like this
SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.